Correlation Between Sanofi ADR and Protagonist Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanofi ADR and Protagonist Therapeutics, you can compare the effects of market volatilities on Sanofi ADR and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and Protagonist Therapeutics.

Diversification Opportunities for Sanofi ADR and Protagonist Therapeutics

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sanofi and Protagonist is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and Protagonist Therapeutics go up and down completely randomly.

Pair Corralation between Sanofi ADR and Protagonist Therapeutics

Considering the 90-day investment horizon Sanofi ADR is expected to generate 0.55 times more return on investment than Protagonist Therapeutics. However, Sanofi ADR is 1.81 times less risky than Protagonist Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  4,839  in Sanofi ADR on October 23, 2024 and sell it today you would earn a total of  235.00  from holding Sanofi ADR or generate 4.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sanofi ADR  vs.  Protagonist Therapeutics

 Performance 
       Timeline  
Sanofi ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanofi ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sanofi ADR is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Protagonist Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Protagonist Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sanofi ADR and Protagonist Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanofi ADR and Protagonist Therapeutics

The main advantage of trading using opposite Sanofi ADR and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.
The idea behind Sanofi ADR and Protagonist Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges